Panel recommends easing restrictions on rosiglitazone despite concerns about cardiovascular safety.
Mitka M; JAMA, 2013, vol. 310, issue 3, p 246, ISSN 15383598. ISBN 15383598.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef